In Reply

Affiliations

Comment

Timothy J Wigmore et al. Anesthesiology. 2016 Aug.

. 2016 Aug;125(2):420-2.

doi: 10.1097/ALN.0000000000001177.

¹ Royal Marsden Foundation Trust, London, United Kingdom (T.J.M.). timothy.wigmore@rmh.nhs.uk.

No abstract available

Comment on

Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis.
Wigmore TJ, Mohammed K, Jhanji S. Wigmore TJ, et al. Anesthesiology. 2016 Jan;124(1):69-79. doi: 10.1097/ALN.0000000000000936. Anesthesiology. 2016. PMID: 26556730
Survival Advantage with Total Intravenous Anesthesia in Cancer Surgery: Is This Confounded by Cancer Type and Stage?
Doleman B, Lund JN, Williams JP. Doleman B, et al. Anesthesiology. 2016 Aug;125(2):417. doi: 10.1097/ALN.0000000000001173. Anesthesiology. 2016. PMID: 27433750 No abstract available.
Total Intravenous Anesthesia and Transfusion: A Double Whammy?
Dawson SA. Dawson SA. Anesthesiology. 2016 Aug;125(2):418-9. doi: 10.1097/ALN.0000000000001175. Anesthesiology. 2016. PMID: 27433752 No abstract available.
Long-term Survival, All-cause Mortality, and Propensity Score Matching.
Ali U, Ghori A. Ali U, et al. Anesthesiology. 2016 Aug;125(2):419-20. doi: 10.1097/ALN.0000000000001176. Anesthesiology. 2016. PMID: 27433753 No abstract available.